Loading data for IMCC — first visit, this takes a few seconds.
IM Cannabis Corp. (IMCC)
NasdaqCM: IMCC
· Real-Time Price · USD
0.11
+0.00 (0.00%)
At close: Aug 21, 2026, 8:00 PM
0.11
-3.37%
After-hours: 7:23 PM
The price, the headline numbers and the latest news, in one place.
IM Cannabis Corp. (IMCC) Stock Price, Analysis & Data
0.00% (1D)
No data available
| Bid | 0.1 |
| Market Cap | 1.84M |
| Revenue (ttm) | 45.8M |
| Net Income (ttm) | -17.92M |
| 2.11 | |
| -2.48 | |
| n/a | |
| -0.09 | |
| P/B (ttm) | -0.26 |
| P/S (ttm) | 0.04 |
| Earnings Date | n/a |
| Ask | 0.12 |
| Volume | 803,807 |
| Avg. Volume (20D) | 6,130,048 |
| Open | 0.12 |
| Previous Close | 0.11 |
| Day's Range | 0.11 - 0.12 |
| 52-Week Range | 0.09 - 2.61 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About IMCC
IM Cannabis Corp. engages in importation, distribution and sale of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and full-spectrum cannabis extracts under the IMC, BLKMT, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Vancouver, Canada....
Sector Healthcare
IPO Date May 20, 2020
Employees 44
Stock Exchange NasdaqCM
Ticker Symbol IMCC
Website https://imcannabis.com
Financial Performance
In 2025, IM Cannabis's revenue was 54.73M, an increase of 1.3% compared to the previous year's 54.03M. Earnings were -11.32M, an increase of 6.93%.
Financial StatementsEarnings Surprise
IM Cannabis has released their quarterly earnings on Mar 31, 2025:
- Revenue of $8.68M misses estimates by $0, with -30.57% YoY decline.
- EPS of -0.22 exceeds estimates by 0.32, with 85.33% YoY growth.
